Business Description
Tevogen Inc
NAICS : 541714
SIC : 8731
ISIN : US88165K1016
Total Employee Number:
18Compare
Compare
Traded in other countries / regions
TVGN.USAG280.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2024-02-15Description
Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | -2 | |||||
Debt-to-Equity | -0.96 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year FCF Growth Rate | -134.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.33 | |||||
9-Day RSI | 60 | |||||
14-Day RSI | 54.9 | |||||
3-1 Month Momentum % | -46.71 | |||||
6-1 Month Momentum % | -64.14 | |||||
12-1 Month Momentum % | -89.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.29 | |||||
Quick Ratio | 0.29 | |||||
Cash Ratio | 0.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.3 | |||||
Shareholder Yield % | -20.37 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -482.27 | |||||
ROIC % | -478.37 | |||||
3-Year ROIIC % | 7.16 | |||||
ROC (Joel Greenblatt) % | -1549.44 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -2.16 | |||||
EV-to-EBITDA | -2.21 | |||||
EV-to-Forward-Revenue | 0.16 | |||||
EV-to-FCF | -3.88 | |||||
Earnings Yield (Greenblatt) % | -46.3 | |||||
FCF Yield % | -41.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TVGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tevogen Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -6.69 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 101.68 | ||
| 14-Day RSI | 54.9 | ||
| 14-Day ATR ($) | 0.683771 | ||
| 20-Day SMA ($) | 5.9255 | ||
| 12-1 Month Momentum % | -89.76 | ||
| 52-Week Range ($) | 3.6364 - 49.5 | ||
| Shares Outstanding (Mil) | 4.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tevogen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tevogen Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 90 days | ||
| General meeting for 2025 | 2026-08-24 13:30 | In 10 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | 6.57 (+0.77%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 9.42 (+43.38%) | ||
| Annual report for 2025 | 2026-03-31 | 4.29 (-1.61%) | ||
| 0.02:1 Stock Split | 2026-03-06 | 7.76 (-13.83%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 22.22 (-3.60%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 50.50 (+5.21%) | ||
| General meeting for 2024 | 2025-06-23 11:00 | 60.00 (-1.64%) | ||
| First quarter earnings results for 2025 | 2025-05-14 | 58.00 (-3.33%) |
Show
Entries
Tevogen Inc Frequently Asked Questions
What is Tevogen Inc(TVGN)'s stock price today?
The current price of TVGN is $6.65. The 52 week high of TVGN is $49.50 and 52 week low is $3.64.
When is next earnings date of Tevogen Inc(TVGN)?
The next earnings date of Tevogen Inc(TVGN) is 2026-11-13 Est..
Does Tevogen Inc(TVGN) pay dividends? If so, how much?
Tevogen Inc(TVGN) does not pay dividend.
Guru Commentaries on NAS:TVGN
No articles.
